"Our best tool against breast cancer is early detection," said...
Category:
Health
Latest
Blood delivery by drones across India may soon be reality, says official after ICMR’s successful trial run
''Today, we are transporting blood and blood-related products which...
Research reveals environment impacts mental health of young people
Young people living in health-constraining environments -areas with...
India’s COVID-19 caseload rises to 97.35 lakh; recoveries cross 92 lakh
The number of people who have recuperated from the disease surged to 92,15,581, pushing the national recovery rate to 94.66 per cent, while the COVID-19 case fatality rate stood at 1.45 per cent.
There are 3,78,909 active coronavirus infections in the country now which comprises 3.89 per cent of the total caseload, the data stated.
The COVID-19 active caseload remained below four lakh for the third consecutive day.
Those vaccinated against Covid-19 may still need to wear masks
“A lot of people are thinking that once they get vaccinated, they’re not going to have to wear masks anymore,” said Michal Tal, an immunologist at Stanford University. “It’s really going to be critical for them to know if they have to keep wearing masks, because they could still be contagious.”
AstraZeneca’s Covid-19 vaccine 70.4% effective at preventing the infection
The Company is also making rapid progress in manufacturing with a capacity of up to 3 billion doses of the vaccine in 2021 on a rolling basis, pending regulatory approval. The vaccine can be stored, transported and handled at normal refrigerated conditions (2-8 degrees Celsius/ 36-46 degrees Fahrenheit) for at least six months and administered within existing healthcare settings.
Nifty, Sensex hit record highs on vaccine progress
Global equities traded higher on Wednesday, after Britain started mass-vaccinating its people using a fully-tested COVID-19 shot and as Johnson & Johnson said it could obtain late-stage trial results for a single-dose vaccine earlier than expected.
Munich Re’s “Ambition 2025” sets new growth and results targets
Return on equity to increase to 12–14% by 2025
Solvency ratio to remain in the ideal corridor of 175–220%
Extensive decarbonisation strategy: Shifting away from coal, oil and natural gas“
“With our Munich Re Group Ambition 2025, we’ve created a strategy that is uniform across the Group – spanning reinsurance, primary insurance and asset management. We have committed ourselves to ambitious financial targets, and we will continue adding value for our shareholders, clients, staff and communities. The Munich Re Group Ambition 2025 will help us to elevate Munich Re to a new level of success.”said Joachim Wenning,Chairman of the Board of Management
UK warns people with serious allergies to avoid Pfizer vaccine after two adverse reactions
“Any person with a history of a significant allergic reaction to a vaccine, medicine or food (such as previous history of anaphylactoid reaction or those who have been advised to carry an adrenaline autoinjector) should not receive the Pfizer BioNtech vaccine,” it said.
Provide more safety data on COVID-19 vaccines: CDSCO expert panel to Serum Institute, Bharat Biotech
“Serum Institute of India has been asked for an updated safety data of phase 2 and 3 clinical trial in the country and immunogenicity data from the clinical trial in the United Kingdom and India. While considering the application of Bharat Biotech company, the SEC after detailed evaluation recommended that the pharma major should submit the safety and efficacy data from its ongoing phase 3 clinical trial in India for more analysis,” a source said.
The application submitted by the Pfizer was not discussed at the SEC meeting as the company has requested for more time for giving its presentation, sources said.
IRDAI revamps Personal Accident Policy, makes it a mandatory product for all general insurers
The Standard Personal Accident Product product will have Death: Benefit equal to 100% of sum insured payable on death of the insured person, due to an injury sustained in an accident during the policy period, provided that the insured person’s death occurs within 12 months from the date of the accident
Bharat Bio working on nasal vaccine
Krishna Ella, chairman and MD, Bharat Biotechsaid said his firm is setting up two more facilities for manufacturing vaccines, including for Covaxin.
India’s Covid-19 tally hits 9.7-million mark as it reports 26,567 new cases
Till now 91,78,946 have recovered, while there are 3,83,866 active cases.
The recovery rate stands at 94.59 per cent, and the fatality rate is 1.45 as per cent.
Maharashtra continues to be the worst-hit state with 18,55,341 cases till date. Over 70 per cent of the daily new cases were reported by 10 states and UT — Maharashtra, Delhi, West Bengal, Haryana, Kerala, Uttar Pradesh, Chhattisgarh, Rajasthan, Punjab, Himachal Pradesh.